Search research articles
Contact Us
Filters
Showing results (51-60 of 112) with videos related to
Page
of 12
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
December 12, 2018
Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer
Elisa Capizzi, Costantino Ricci, Francesca Giunchi, et al.
Virchows Archiv : an International Journal of Pathology
|
December 10, 2021
Low level of interobserver concordance in assessing histological subtype and tumor grade in patients with penile cancer may impair patient care
Luiza Dorofte, Diane Grélaud, Michelangelo Fiorentino, et al.
Pathology, Research and Practice
|
December 12, 2022
Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1…but choriocarcinoma?
Costantino Ricci, Francesca Ambrosi, Tania Franceschini, et al.
BMC Medical Research Methodology
|
December 7, 2018
Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies
Jessica Carlsson, Sabina Davidsson, Jonna Fridfeldt, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
April 8, 2014
First case of bilateral, synchronous anaplastic variant of spermatocytic seminoma treated with radical orchifunicolectomy as single approach: case report and review of the literature
Giorgio Gentile, Francesca Giunchi, Riccardo Schiavina, et al.
Expert Review of Anticancer Therapy
|
August 8, 2020
Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors
Veronica Mollica, Ilaria Maggio, Antonio Lopez-Beltran, et al.
Pathology, Research and Practice
|
March 25, 2021
Impact of HER2 assessment by CISH in urothelial carcinoma: A retrospective single-center experience
Alessandro Rizzo, Veronica Mollica, Francesca Giunchi, et al.
Pathology, Research and Practice
|
April 15, 2025
Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience
Matteo Rosellini, Veronica Mollica, Andrea Marchetti, et al.
Cancers
|
June 6, 2020
Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma
Veronica Mollica, Alessandro Rizzo, Rodolfo Montironi, et al.
Cancers
|
March 29, 2023
Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with <sup>68</sup>Ga-PSMA PET/CT Features in Primary Staging
Luigia Vetrone, Riccardo Mei, Lorenzo Bianchi, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 112) with videos related to
Sort By:
Page
of 12
Lung Cancer (Amsterdam, Netherlands)
|
December 12, 2018
Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer
Elisa Capizzi, Costantino Ricci, Francesca Giunchi, et al.
Virchows Archiv : an International Journal of Pathology
|
December 10, 2021
Low level of interobserver concordance in assessing histological subtype and tumor grade in patients with penile cancer may impair patient care
Luiza Dorofte, Diane Grélaud, Michelangelo Fiorentino, et al.
Pathology, Research and Practice
|
December 12, 2022
Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1…but choriocarcinoma?
Costantino Ricci, Francesca Ambrosi, Tania Franceschini, et al.
BMC Medical Research Methodology
|
December 7, 2018
Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies
Jessica Carlsson, Sabina Davidsson, Jonna Fridfeldt, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
April 8, 2014
First case of bilateral, synchronous anaplastic variant of spermatocytic seminoma treated with radical orchifunicolectomy as single approach: case report and review of the literature
Giorgio Gentile, Francesca Giunchi, Riccardo Schiavina, et al.
Expert Review of Anticancer Therapy
|
August 8, 2020
Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors
Veronica Mollica, Ilaria Maggio, Antonio Lopez-Beltran, et al.
Pathology, Research and Practice
|
March 25, 2021
Impact of HER2 assessment by CISH in urothelial carcinoma: A retrospective single-center experience
Alessandro Rizzo, Veronica Mollica, Francesca Giunchi, et al.
Pathology, Research and Practice
|
April 15, 2025
Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience
Matteo Rosellini, Veronica Mollica, Andrea Marchetti, et al.
Cancers
|
June 6, 2020
Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma
Veronica Mollica, Alessandro Rizzo, Rodolfo Montironi, et al.
Cancers
|
March 29, 2023
Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with <sup>68</sup>Ga-PSMA PET/CT Features in Primary Staging
Luigia Vetrone, Riccardo Mei, Lorenzo Bianchi, et al.
Page
of 12